Dementia Big
Accurate estimates of cognitive and clinical decline rates are essential to the design of clinical trials in Alzheimer’s disease (AD) dementia.
http://ift.tt/1Os8V2y
Tuesday, February 23, 2016
Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials
Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials:
http://ift.tt/1Os8V2y
http://ift.tt/1Os8V2y
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment